Article

Re-Evaluating Breast Malignant Pleural Effusion: Toward Evidence-Based, Precision-Aligned Care with Organoids

2026-02-13

Abstract excerpt

Breast cancer–associated malignant pleural effusion (MPE) is a common and debilitating manifestation of advanced disease, yet current management is largely limited to indwelling pleural catheters and chemical pleurodesis and offers only transient palliation without addressing the underlying tumor biology. We propose that integrating patient-derived organoid modeling of pleural tumor cells with characterization via...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 720704f3-33ae-52f5-bc1d-6957109eb317
DOI: 10.20944/preprints202511.1952.v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Re-Evaluating Breast Malignant Pleural Effusion: Toward Evidence-Based, Precision-Aligned Care with OrganoidsDOI 10.20944/preprints202511.1952.v3Read

Re-Evaluating Breast Malignant Pleural Effusion: Toward Evidence-Based, Precision-Aligned Care with OrganoidsSemantic proximity Read

Multi-omic profiling of pleural effusions: a reservoir-incubator for non-invasive insights into tumor heterogeneitySemantic proximity Read

Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions.Semantic proximity Read

Patient-derived organoids from malignant pleural effusion to explore for alternative therapies in thoracic tumorsSemantic proximity Read

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors.Semantic proximity Read

Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.Semantic proximity Read

Non-Animal Models for Studying the Effects of Chemotherapeutic Drugs on Breast Cancer MetastasisSemantic proximity Read

Ex vivo drug testing in metastatic biopsies reveals patient-specific vulnerabilities to cancer targeting and immune activating drugsSemantic proximity Read

Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicineSemantic proximity Read

Diagnostic molecular biomarkers for malignant pleural effusions.Semantic proximity Read

Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapiesSemantic proximity Read

Patient-derived organoid models of malignant phyllodes tumours for drug sensitivity testing and identification of targeted therapeutic strategies.Semantic proximity Read